Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics

Glioblastoma (GBM) is the most aggressive malignant brain tumour, with a median survival of 3 months without treatment and 15 months with treatment. Early GBM diagnosis can significantly improve patient survival due to early treatment and management procedures. Magnetic resonance imaging (MRI) using...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zijun, Dai, Lixiong, Tang, Ke, Ma, Yiqi, Song, Bin, Zhang, Yanrong, Li, Jinxing, Lui, Su, Gong, Qiyong, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634494/
https://www.ncbi.nlm.nih.gov/pubmed/34868634
http://dx.doi.org/10.1093/rb/rbab062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634494/
https://www.ncbi.nlm.nih.gov/pubmed/34868634
http://dx.doi.org/10.1093/rb/rbab062

Ejemplares similares